Cargando…
Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort study
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD). Cardiovascular risk assessment in this population is hampered by the failure of traditional risk factors to fully account for the elevated CVD risk (reverse epidemi...
Autores principales: | Junyent, Mireia, Martínez, Montserrat, Borràs, Mercè, Coll, Blai, Valdivielso, Jose Manuel, Vidal, Teresa, Sarró, Felipe, Roig, Jordi, Craver, Lourdes, Fernández, Elvira |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919528/ https://www.ncbi.nlm.nih.gov/pubmed/20609210 http://dx.doi.org/10.1186/1471-2369-11-14 |
Ejemplares similares
-
Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study
por: Arroyo, David, et al.
Publicado: (2014) -
Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort
por: Valls, Joan, et al.
Publicado: (2019) -
A low fractional excretion of Phosphate/Fgf23 ratio is associated with severe abdominal Aortic calcification in stage 3 and 4 kidney disease patients
por: Craver, Lourdes, et al.
Publicado: (2013) -
High Levels of Hemoglobin Promote Carotid Adventitial Vasa Vasorum Neoangiogenesis in Chronic Kidney Disease
por: Arcidiacono, Maria Vittoria, et al.
Publicado: (2017) -
The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease
por: Borràs Sans, Mercè, et al.
Publicado: (2017)